drugset / Trial / NCT00215384

Study in Patients With COPD

NCT00215384 ↗

Phase 2 Completed 35 enrolled Dey
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.

Timeline

Start
—
Primary completion
2003-04
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified — —